Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

Green light for Amryt's epidermolysis bullosa study

pharmatimesJanuary 08, 2019

Tag: IDCM , Amryt , Epidermolysis bullosa , trial

PharmaSources Customer Service